Ross Moat

Insider Reports History

Entity
Individual
Location
C/O Kiniksa Pharmaceuticals Ltd., Clarendon House, 2 Church Street, Hamilton, Bermuda
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ross Moat:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kiniksa Pharmaceuticals International, plc CHIEF COMMERCIAL OFFICER Class A Ordinary Share 21.7K $589K $27.12 Sep 3, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. CHIEF COMMERCIAL OFFICER Class A Common Share 16.3K $291K $17.90 Apr 8, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. CHIEF COMMERCIAL OFFICER Performance Share Unit 5.57K $99.7K $17.90 Apr 4, 2024 Direct
Kiniksa Pharmaceuticals International, plc CHIEF COMMERCIAL OFFICER Share Option 30.9K Sep 3, 2024 Direct
Kiniksa Pharmaceuticals, Ltd. CHIEF COMMERCIAL OFFICER Restricted Share Unit 9.32K Apr 8, 2024 Direct
Kiniksa Pharmaceuticals International, plc CHIEF COMMERCIAL OFFICER Restricted Share Unit 994 Sep 2, 2024 Direct

Insider Reports Filed by Ross Moat

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNSA Kiniksa Pharmaceuticals International, plc Jul 15, 2024 18 -$1.08M 4 Sep 4, 2024 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 4, 2024 6 -$24.2K 4 Apr 8, 2024 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2024 3 -$17.3K 4 Apr 3, 2024 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Jul 15, 2023 9 -$30.1K 4 Sep 6, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 10, 2023 3 -$14.5K 4 Apr 11, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 1, 2023 2 $0 4 Apr 3, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Jan 15, 2023 7 -$1.57K 4 Mar 20, 2023 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 1, 2022 6 -$3K 4 Sep 6, 2022 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Apr 7, 2022 2 $0 4 Apr 11, 2022 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Mar 21, 2022 3 -$13.6K 4 Mar 23, 2022 CHIEF COMMERCIAL OFFICER
KNSA Kiniksa Pharmaceuticals, Ltd. Sep 2, 2021 2 $0 4 Sep 7, 2021 ARCALYST General Manager
KNSA Kiniksa Pharmaceuticals, Ltd. Jul 15, 2021 5 $20.4K 4 Mar 18, 2022 Chief Commercial Officer